Multifaceted COVID-19 Associated Coagulopathy

被引:0
|
作者
Bhardwaj, Manisha [1 ,4 ]
Himral, Pratibha [2 ]
Aggarwal, Deepak [3 ]
机构
[1] Shri Lal Bahadur Shastri Govt Med Coll & Hosp Mand, Dept Pulm Med, Mandi, Himachal Prades, India
[2] Shri Lal Bahadur Shastri Govt Med Coll & Hosp Mand, Dept Internal Med, Mandi, Himachal Prades, India
[3] Govt Med Coll & Hosp, Dept Pulm Med, Chandigarh, India
[4] Shri Lal Bahadur Shastri Govt Med Coll & Hosp Mand, Dept Pulm Med, Ner Chowk 175021, Himachal Prades, India
关键词
Complications; COVID-19; SARS-CoV-2; Thrombosis; COMPLICATIONS;
D O I
10.7860/JCDR/2023/61329.17462
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pathophysiology behind Coronavirus Disease-2019 (COVID-19) has remained blur even after more than two years of onset of the pandemic. Apart from pulmonary parenchymal involvement, widespread vascular thrombosis affecting both pulmonary and extra-pulmonary systems has also been seen to contribute to COVID-19 associated morbidity. This vascular manifestation often remains undiagnosed due to non specific and varied symptoms that range from asymptomatic detection to life threatening presentations. A series of six COVID-19 positive (three male and three female) cases who presented with thrombosis of pulmonary, coronary and cerebral vessels despite being on thromboprophylaxis are reported herein. The age of patients ranged from 32 to 80 years. Out of six patients, three had comorbidities. The most common complication was Pulmonary Thromboembolism (PTE, n=4) followed by Myocardial Infarction (MI, n=1) and cerebellar infarct (n=1). Out of three patients with PTE, one patient had concurrent Deep Vein Thrombosis (DVT). All patients were managed as per guidelines issued by the Ministry of Health and Family Welfare for severe COVID-19 disease. Out of six patients, three patients died and three were discharged. The series highlights the need for high index of suspicion on the part of the treating physician that could aid in early detection and successful management of this potentially fatal condition.
引用
收藏
页码:OR1 / OR4
页数:4
相关论文
共 50 条
  • [1] Coagulopathy associated with COVID-19
    Lee, Stephanie G.
    Fralick, Michael
    Sholzberg, Michelle
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (21) : E583 - E583
  • [2] COVID-19 update: Covid-19-associated coagulopathy
    Richard C. Becker
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 50 : 54 - 67
  • [3] COVID-19 update: Covid-19-associated coagulopathy
    Becker, Richard C.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (01) : 54 - 67
  • [4] COVID-19 associated coagulopathy: A bibliometric investigation
    Alshaikh, Nahla A.
    [J]. HELIYON, 2023, 9 (06)
  • [5] COVID-19 associated coagulopathy and thrombosis in cancer
    Levi, Marcel
    van Es, Nick
    [J]. THROMBOSIS RESEARCH, 2022, 213 : S72 - S76
  • [6] COVID-19 Associated Coagulopathy and Thrombotic Complications
    Mezalek, Zoubida Tazi
    Khibri, Hajar
    Ammouri, Wafaa
    Bouaouad, Majdouline
    Haidour, Soukaina
    Harmouche, Hicham
    Maamar, Mouna
    Adnaoui, Mohamed
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [7] Coagulopathy and COVID-19
    Lorini, Ferdinando Luca
    Di Matteo, Maria
    Gritti, Paolo
    Grazioli, Lorenzo
    Benigni, Alberto
    Zacchetti, Lucia
    Bianchi, Isabella
    Fabretti, Fabrizio
    Longhi, Luca
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0E) : E95 - E98
  • [8] Coagulopathy and COVID-19
    Ploplis, Victoria A.
    [J]. CURRENT DRUG TARGETS, 2022, 23 (17) : 1537 - 1538
  • [9] Coagulopathy and COVID-19
    Yazici, Onur
    Bozkus, Fulsen
    Demirci, Nilgun
    Gulhan, Pinar Yildiz
    Coskun, Funda
    [J]. EURASIAN JOURNAL OF PULMONOLOGY, 2020, 22 (04) : 67 - 69
  • [10] COVID-19 and coagulopathy
    Sarkar, Malay
    Madabhavi, Irappa, V
    Pham Nguyen Quy
    Govindagoudar, Manjunath B.
    [J]. CLINICAL RESPIRATORY JOURNAL, 2021, 15 (12): : 1259 - 1274